MHELTHERA Presentations
Talks
2024
-
Jürgen Kogler
Development of multimodal FAPI-PET radiotracers for preoperative PET imaging and fluorescence-guided surgery
62. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin (DGN), Leipzig (Germany), April 10-13, 2024
- Michael Bachmann
Combinatorial theranostic targeting of tumors and the tumor microenvironment
7th Theranostic World Congress, Santiago (Chile), March 22-24, 2024
- Anja Feldmann
Theranostic target molecules for adapter CAR-T cell therapies
26. Jahressymposium Interdisziplinäre Gruppe for Labor und Durchflusszytometrie (IGLD), Leipzig (Germany), March 7, 2024
2023
- Liliana Loureiro
Cancer immunotheranostics using adaptor CAR technologies and target modules
2023 HZDR Science Conference, Dresden (Germany), November 15 – 16, 2023
-
Christin Neuber
FAP-gerichtete Target Module für die Radionuklid-Theranostik und UniCAR T‑Zell-Therapie
Arbeitsgemeinschaft Radiochemie/Radiopharmazie, 1. Jahrestagung der GRPW e. V., Bad Salzuflen (Germany), September 28 – 30, 2023
-
Jürgen Kogler
Development of FAPI-PET Radiotracers for bimodal imaging and fluorescent-guided surgery
Arbeitsgemeinschaft Radiochemie/Radiopharmazie, 1. Jahrestagung der GRPW e. V., Bad Salzuflen (Germany), September 28 – 30, 2023
- Christin Neuber
FAP directed target modules for UniCAR T cell therapy and radionuclide-based tumour theranostics
European Association of Nuclear Medicine 2023, Vienna (Austria), September 09 – 13, 2023
- Larysa Baraban
Biodetection platforms based on the extended gate FETs
International Conference on Functional Nanomaterials and Nanodevices 2023, Warsaw (Poland), August 28 – 30, 2023
- Željko Janićijević
Biodetection platforms based on the extended gate FETs
Hengstberger Symposium on Bioelectronics: "mimicking and interfacing biological systems", Heidelberg (Germany), May 15 – 17, 2023
- Anja Feldmann
Wie Dresdner Forschende Immunzellen gegen Krebs nutzen
SaxoCell Lecture, Dresden (Germany), February 10, 2023
2022
- Claudia Arndt
Mildred-Scheel-Nachwuchszentrum Dresden: allogene UniCAR T-Zellen zur Behandlung und Therapieüberwachung der akuten myeloischen Leukämie35
Deutschen Krebskongress 2022 (DKK 2022), Berlin (Germany), November 15, 2022
- Kellie Tuck
Innovative sensing technologies – from lanthanide-based complexes to fluorescent labelled peptides
Seminar, HZDR, Dresden (Germany), November 11, 2022
- Holger Stephan
Bimodal Chelating Systems for Molecular Imaging
Seminar, Kitakyushu University, Kitakyushu (Japan), October 12, 2022;
Seminar, Saga University, Saga (Japan), October 19, 2022
- Holger Stephan
Multifunctional Stealth Nanoparticles for Biomedical Applications
Seminar, Sophia University Tokyo (Japan), October 7, 2022;
Seminar, Kyushu University, Fukuoka (Japan), October 19, 2022
Seminar, The University of Tokyo, Tokyo (Japan), November 1, 2022
- Claudia Arndt
Breaking new ground - How CAR technology can change the landscape of cancer theranostics
Seminar Series, Central Clinical School, Monash University, Melbourne (Australia), October 14, 2022
- Liliana Loureiro
Driving modular CARs through solid tumours and their microenvironment - a new era in cancer immunotherapy
Seminar Series, Central Clinical School, Monash University, Melbourne (Australia), October 14, 2022
- Manja Kubeil
Radiopharmaceutical evaluation of bifunctional chelators and bioconjugates for tumour imaging and therapy
Seminar, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne (Australia), October 10, 2022;
Webinar lecture, Monash Biomedical Imaging, Melbourne (Australia), October 12, 2022;
Seminar, University of Queensland, Brisbane (Australia), October 13, 2022
- Claudia Arndt (Plenary Lecture)
CAR Technology Meets Theranostics – A New Era of Immunotheranostics for Hematological and Solid Tumors
Australian Society of Molecular Imaging (ASMI) Annual Meeting 2022, Melbourne (Australia), October 06 – 07, 2022
- Liliana Loureiro
Immunotheranostic target modules suitable for imaging and navigation of UniCAR T-cells to strike FAP-expressing solid tumours and their microenvironment
Australian Society of Molecular Imaging (ASMI) Annual Meeting 2022, Melbourne (Australia), October 6 – 7, 2022
- Manja Kubeil
A novel bispidine-based chelator for radiopharmaceutical applications
Australian Society of Molecular Imaging (ASMI) Annual Meeting 2022, Melbourne (Australia), October 6 – 7, 2022
- Ina Kopp
177Lu- and 225Ac-labelling bispidine conjugates targeting neuroendocrine tumors
FG Nuclear Chemistry of the German Society of Chemistry, Annual Meeting 2022, Bergisch Gladbach (Germany), October 04 – 06, 2022
- Ina Kopp
177Lu-, 225Ac- and 111In-labelled nonadentate bispidine ligands: synthesis, radiolabeling experiments and stability assays
TERACHEM 2022, Convention Center Bressanone (Italy), September 14-17, 2022
- Christin Neuber
FAP directed target modules are suitable for imaging and targeted radionuclide therapy of FAP-expressing solid tumours and their microenvironment
5th GyMIC Molecular Imaging Symposium, Leipzig (Germany), September 15 – 16, 2022
- Anja Feldmann
Theranostic Antibody- and CAR-based Platform Technology for Therapy and Imaging
Antibody Technologies and Therapeutics Conference, Monash University Prato Centre, Italy, September 11 – 14, 2022
- Liliana Loureiro
Driving UniCARs to successful immunotherapy of solid tumors expressing fibroblast activation protein (FAP)
Antibody Technologies and Therapeutics Conference, Monash University Prato Centre (Italy), September 11 – 14, 2022
- Claudia Arndt
Engineered T-Cells for personalized cancer therapy
Precision Oncology Symposium, MSNZ, CRTD, Dresden (Germany), June 15, 2022
- Michael Bachmann (Chair and Lecturer)
Playing Boolean Algebra with CAR T cells: Why and How
International LIT Symposium “Synthetic Immunology / Synthetic Biology”, Regensburg (Germany) June 2022
- Michael Bachmann
Gated Targeting with CAR-T Cells
7th Lithuania International Hematology Oncology Colloquium, Kaunas (Lithuania), May 26, 2022
- Michael Bachmann (Chair and Lecturer)
INCREASING THE SAFETY OF CAR TECHNOLOGY: GATED TARGETING WITH MODULAR CARS
The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022
- Anja Feldmann
ADAPTOR UNICAR AND REVCAR PLATFORMS FOR FLEXIBLE, SWITCHABLE AND COMBINATORIAL TUMOR TARGETING
The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022
- Liliana Loureiro
AS SMALL AS IT CAN BE: SHORT PEPTIDE-DERIVED TARGET MOLECULES FOR REDIRECTION OF UNICAR T-CELLS AND IMAGING OF SSTR2-EXPRESSING CANCERS
The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022
Poster
2023
- Manja Kubeil
Bispidine - One chelator to bind lutetium-177 and actinium-225
25th International Symposium on Radiopharmaceutical Sciences (iSRS), Honolulu (Hawaii), May 22 – May 26, 2023
2022
- Claudia Arndt (3min ePoster Presentation)
UNICAR CAR T CELL THERANOTICS FOR DIAGNOSTIC IMAGING AND THERAPY OF PROSTATE CANCER
The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022
URL of this article
https://www.hzdr.de/db/Cms?pOid=67722